Sandra and Edward Meyer Cancer Center

You are here

Research Programs

Our translational and clinical researchers collaborate to convert conceptual breakthroughs into novel therapies that will benefit our patients. They work in multidisciplinary teams that focus on translational research targeting individual cancers, as well as those focused on basic research that crosses multiple diseases across the cancer continuum. An additional population science program investigates the links between cancer and obesity. 

Gastrointestinal Cancers

Pioneering research and advanced therapies for esophageal cancer, gastric and gastro-esophageal cancer, endocrine cancer, liver cancer, pancreatic cancer and colorectal cancer. Recent advances in understanding of the underlying biology of metastasis, together with advanced molecular profiling of...
See More

Cancer Biology

Investigating the complexities of cancer biology by studying the transcription factors, cellular signaling events and cellular architecture that underlie malignant transformation.
See More

Solid Tumors

Advancing basic bench discoveries within and across disease sites, and apply them to novel clinical trials for solid malignancies
See More

Brain Cancer

Developing and testing the next generation of innovative brain tumor therapies for both adults and children
See More

Breast Cancer

Catalyzing and coordinating translational breast cancer research, and making use of new and emerging technologies and the results of clinical trials to spur drug development and targeted therapeutics.
See More

Hematologic Malignancies

Developing rationally designed, targeted and individualized therapeutic strategies that will minimize the use of conventional toxic and noxious chemotherapeutics in patients with hematologic malignancies.
See More

Lung Cancer

Developing new strategies to detect lung cancer early and treat it differently, using novel targeted therapies
See More

Prostate Cancer

Translating laboratory discoveries into targeted, tailored prevention and treatments for one of the most common cancers in the Western world, affecting 1 in 6 men in the United States
See More